BioSpace News Archive

Brachytherapy Market Size Worth USD 548.8 Million by 2027 | Emergen Research

The global brachytherapy market is projected to be worth USD 548.8 Million by 2027, according to a current analysis by Emergen Research.

August 23, 2022
·
6 min read
Computational Biology Market Size Worth USD 16.58 Billion by 2027 | Emergen Research

The global Computational Biology Market is forecasted to be worth USD 16.58 Billion by 2027, according to a current analysis by Emergen Research.

August 23, 2022
·
6 min read
Combination Cancer Therapy Clinical Trials Report 2028

Kuick Research Report Gives Comprehensive Clinical & Commercial Opportunity Insights More Than 600 Combination Cancer Drugs In Clinical Trials

August 23, 2022
·
4 min read
Hepatorenal Syndrome Treatment Market is Growing at a 5% from 2022 to 2030

The global hepatorenal syndrome treatment market was valued at ~US$ 11 Bn in 2018 and is projected to reach a value of ~US$ 16.7 Bn by 2030, expanding at a CAGR of ~5% from 2022 to 2030.

August 23, 2022
·
12 min read
Systemic Lupus Erythematosus Treatment Market Size, Growth, Trends, Report 2022 to 2030

The global systemic lupus erythematosus treatment market is projected to grow at a CAGR of ~7%, and reach a valuation of ~US$ 3 Bn by the year 2030.

August 23, 2022
·
10 min read
Amniotic Membrane Market is Growing at a CAGR 10% from 2022 to 2030

Chronic burn wounds lead to trauma amongst patients. What adds to the patient’s difficulty is the risk of infection, sepsis, joint problems, and scarring during the management of third-degree burns.

August 23, 2022
·
11 min read
Cough Hypersensitivity Syndrome Treatment Market Size USD 11 BN by 2030

The cough hypersensitivity syndrome treatment market is projected to increase at a CAGR of 5.5%, from a value of ~US$ 7 Bn in 2022 to ~US$ 11 Bn by the year 2030.

August 23, 2022
·
9 min read
Drug Development

Segal Trials Participation in Study Shows Positive Results From Phase 3 EMERGENT-2 KarXT in Schizophrenia

Segal Trials, a privately held network of clinical research sites throughout South Florida has concluded a phase 3 EMERGENT-2 trial with Karuna Therapeutics.

August 23, 2022
·
3 min read
Biotech Bay

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference.

August 23, 2022
·
1 min read
Pharma PLM Market to Rear Excessive Growth During 2020 – 2030

Wilmington, Delaware, United States, Transparency Market Research Inc.: Product Lifecycle Management (PLM) is used for maximizing the revenue generation capabilities of pharma companies

August 23, 2022
·
5 min read